Episurf Medical AB

Equities

EPIS B

SE0003491562

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 11:29:43 2024-04-24 am EDT 5-day change 1st Jan Change
0.3985 SEK +7.70% Intraday chart for Episurf Medical AB -47.29% -59.75%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Episurf Medical Plans SEK120 Million Rights Issue MT
Episurf Medical AB Elects Jess Lonner as New Member of the Board of Directors CI
Episurf Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Sweden's Episurf Medical Secures New Patents in Asia, South Africa MT
Episurf Medical AB Receives Four Additional Patent Approval Notification CI
Episurf Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Episurf Medical Announces 510(k) Submission for Big Toe Implant CI
Episurf Members Announces Nomination Committee for Episurf Medical's Annual General Meeting in 2024 CI
Episurf Medical Announces Early Clinical Results from Episealer Talus Study Presented at Scientific Congress CI
Episurf Medical Announces Prospective Episealer Talus Clinical Study CI
Episurf Medical's New Knee Joint Implant System Scheduled For Surgery Use in US MT
Episurf Medical AB Announces First Commercial Case in the US Has Been Scheduled for Surgery CI
Episurf Announces Results from the Use of Episealer Accepted for Publication in Scientific Journal CI
Episurf Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Episurf Medical Wins Hospital Value Analysis Committee's Approval for Implant System MT
Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Episurf Medical Builds US Distributor Network for Episealer Patellofemoral System MT
Episurf Medical Receives Another Granted Patent in India CI
Episurf Medical Receives Another Notice of Allowance from the United States Patent and Trademark Office CI
Episurf Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Episurf Medical AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Episurf Medical AB Announces Dennis Stripe Not Stand for Re-Election as Chairman of the Board of Directors CI
Episurf Medical AB Receives Notice of Allowance from the United States Patent and Trademark Office CI
Episurf Medical Wins US FDA Approval for Patellofemoral Implant System MT
Episurf Medical AB Receives FDA 510(k) clearance for Episealer® Patellofemoral System CI
Chart Episurf Medical AB
More charts
Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Company’s product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the knee’s surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EPIS B Stock
  4. News Episurf Medical AB
  5. Episurf Medical's First Ankle Implant Surgery Scheduled In Belgium